SQZ Biotechnologies Company (SQZB)
OTCMKTS: SQZB · Delayed Price · USD
0.0465
0.00 (0.00%)
Apr 30, 2024, 12:00 AM EDT - Market open

SQZB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2022202120202019
Market Capitalization
122251716-
Market Cap Growth
--91.30%-65.01%--
Enterprise Value
-16-17175591-58
PE Ratio
-0.22-0.27-3.65-14.18-
PS Ratio
0.081.019.2534.11-
PB Ratio
0.040.382.025.63-
P/FCF Ratio
-0.19-0.26-3.03-16.16-
P/OCF Ratio
-0.19-0.26-3.05-16.60-
EV/Sales Ratio
-0.06-0.786.4428.13-2.90
EV/EBITDA Ratio
0.020.25-3.02-14.932.09
EV/EBIT Ratio
0.020.21-2.54-11.691.81
EV/FCF Ratio
0.010.20-2.11-13.331.63
Debt / Equity Ratio
0.610.480.560.37-0.58
Debt / EBITDA Ratio
-0.38-0.41-1.21-1.19-1.52
Debt / FCF Ratio
-0.28-0.33-0.84-1.06-1.19
Quick Ratio
3.323.024.483.862.68
Current Ratio
3.503.124.533.912.66
Asset Turnover
0.150.140.110.110.15
Return on Equity (ROE)
-119.80%-99.70%-47.50%-188.20%55.00%
Return on Assets (ROA)
-59.90%-50.00%-28.30%-26.30%-24.00%
Return on Capital (ROIC)
-120.46%-95.35%-35.51%-29.29%109.88%
Earnings Yield
-5172.11%-364.62%-27.43%-7.05%-
FCF Yield
-5928.63%-385.61%-33.02%-6.19%-
Buyback Yield / Dilution
-4.78%-4.47%-410.54%-216.92%-7.43%
Total Shareholder Return
-4.78%-4.47%-410.54%-216.92%-7.43%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).